Sinovac Biotech Ltd (NASDAQ:SVA)

4.92
Delayed Data
As of 4:00pm ET
 -0.04 / -0.81%
Today’s Change
4.51
Today|||52-Week Range
7.47
-5.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-12.6M-399.7K-14.9M4.5M
 
 
 
 
 
Depreciation4.2M4.8M4.5M6.7M
 
 
 
 
 
Total Other Cash Flow10.1M3.8M998.4K9.5M
 
 
 
 
 
Funds From Operations4.0K11.1M-9.4M18.5M
 
 
 
 
 
Funds From/For Other Operating Expenses14.3M-2.9M6.9M12.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.3M13.9M-16.3M5.6M
 
 
 
 
 
 
InvestingIncrease In Investments-1.5M0.000.000.00
 
 
Decrease In Investments7.3M1.5M0.000.00
 
 
 
Capital Expenditures-25.4M-15.5M-16.2M-5.2M
 
 
 
 
 
Fixed Asset Disposal231.6K122.1K5.4K0.00
 
 
 
 
Other Investing - Sources64.4K0.000.000.00
 
 
Net Cash Flow Investing-19.2M-13.8M-16.2M-5.2M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings20.0M11.4M16.8M16.8M
 
 
 
 
 
Long Term Debt Reduction-17.9M-10.7M-4.8M-4.1M
 
 
 
 
 
Net Proceeds Stock Sale62.3M752.2K515.7K848.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing372.0K5.0M5.6M860.0K
 
 
 
 
 
Other Uses - Financing6.6M5.9M802.2K0.00
 
 
 
 
Net Cash Flow - Financing58.2M612.9K17.3M14.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash2.0M1.9M2.0M1.2M
 
 
 
 
 
 
Net Change In Cash24.7M758.4K-15.1M14.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account